Global Ketorolac Injection Market Research Report 2021

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,900	94 Pages	QYResearch Group	December, 2021	QYR16864521

Best Price Guarantee
Price	from $2,900
Length	94 Pages
Publisher	QYResearch Group
Published Date	December, 2021
SKU	QYR16864521

Global Ketorolac Injection Market Research Report 2021

Summary

The global Ketorolac Injection market was valued at US$ 967.04 million in 2020 and is expected to reach US$ 1102.17 million by the end of 2027, growing at a CAGR of 2.69% during 2021-2027.
This report focuses on Ketorolac Injection volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Ketorolac Injection market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, India, etc.
Global Ketorolac Injection Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
By Company
Pfizer
Fresenius Kabi
Fosun Pharma (Gland Pharma)
Sagent Pharmaceuticals
Hikma
Lunan Pharm
Alvogen
Chengdu Brilliant Pharmaceuticals
Athenex
Sichuan Medcalo
Julphar Bangladesh Ltd.
Yung Shin Pharm
Tianjin Chase Sun Pharmaceutical
ZISKA Pharmaceuticalshin Pharm

Segment by Type
15mg/ml
30mg/ml

Segment by Application
Hospital
Clinics
Others

By Region
North America
U.S.
Canada

Asia-Pacific
China
Japan
South Korea
India
Australia
Southeast Asia

Europe
Germany
France
U.K.
Italy
Russia

Latin America
Mexico
Brazil
Argentina

Middle East & Africa
Turkey
Saudi Arabia
UAE

1 KETOROLAC INJECTION MARKET OVERVIEW: 1.1 Product Overview and Scope of Ketorolac Injection; 1.2 Ketorolac Injection Segment by Type; 1.2.1 Global Ketorolac Injection Sales Growth Rate Comparison by Type (2021-2027); 1.2.2 15mg/ml; 1.2.3 30mg/ml; 1.3 Ketorolac Injection Segment by Application; 1.3.1 Global Ketorolac Injection Sales Comparison by Application (2021-2027); 1.3.2 Hospital; 1.3.3 Clinics; 1.3.4 Others; 1.4 Global Ketorolac Injection Market Size Estimates and Forecasts; 1.4.1 Global Ketorolac Injection Revenue 2016-2027; 1.4.2 Global Ketorolac Injection Sales 2016-2027; 1.4.3 Ketorolac Injection Market Size by Region: 2016 Versus 2021 Versus 2027
2 KETOROLAC INJECTION MARKET COMPETITION BY MANUFACTURERS: 2.1 Global Ketorolac Injection Sales Market Share by Manufacturers (2016-2021); 2.2 Global Ketorolac Injection Revenue Market Share by Manufacturers (2016-2021); 2.3 Global Ketorolac Injection Average Price by Manufacturers (2016-2021); 2.4 Manufacturers Ketorolac Injection Manufacturing Sites, Area Served, Product Type; 2.5 Ketorolac Injection Market Competitive Situation and Trends; 2.5.1 Ketorolac Injection Market Concentration Rate; 2.5.2 The Global 5 and 10 Largest Ketorolac Injection Players Market Share by Revenue; 2.5.3 Global Ketorolac Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3); 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 KETOROLAC INJECTION RETROSPECTIVE MARKET SCENARIO BY REGION: 3.1 Global Ketorolac Injection Retrospective Market Scenario in Sales by Region: 2016-2021; 3.2 Global Ketorolac Injection Retrospective Market Scenario in Revenue by Region: 2016-2021; 3.3 North America Ketorolac Injection Market Facts & Figures by Country; 3.3.1 North America Ketorolac Injection Sales by Country; 3.3.2 North America Ketorolac Injection Revenue by Country; 3.3.3 U.S.; 3.3.4 Canada; 3.4 Europe Ketorolac Injection Market Facts & Figures by Country; 3.4.1 Europe Ketorolac Injection Sales by Country; 3.4.2 Europe Ketorolac Injection Revenue by Country; 3.4.3 Germany; 3.4.4 France; 3.4.5 U.K.; 3.4.6 Italy; 3.4.7 Russia; 3.5 Asia Pacific Ketorolac Injection Market Facts & Figures by Region; 3.5.1 Asia Pacific Ketorolac Injection Sales by Region; 3.5.2 Asia Pacific Ketorolac Injection Revenue by Region; 3.5.3 China; 3.5.4 Japan; 3.5.5 South Korea; 3.5.6 India; 3.5.7 Australia; 3.5.8 Southeast Asia; 3.6 Latin America Ketorolac Injection Market Facts & Figures by Country; 3.6.1 Latin America Ketorolac Injection Sales by Country; 3.6.2 Latin America Ketorolac Injection Revenue by Country; 3.6.3 Mexico; 3.6.4 Brazil; 3.6.5 Argentina; 3.7 Middle East and Africa Ketorolac Injection Market Facts & Figures by Country; 3.7.1 Middle East and Africa Ketorolac Injection Sales by Country; 3.7.2 Middle East and Africa Ketorolac Injection Revenue by Country; 3.7.3 Turkey; 3.7.4 Saudi Arabia; 3.7.5 UAE
4 KETOROLAC INJECTION HISTORIC MARKET ANALYSIS BY TYPE: 4.1 Global Ketorolac Injection Sales Market Share by Type (2016-2021); 4.2 Global Ketorolac Injection Revenue Market Share by Type (2016-2021); 4.3 Global Ketorolac Injection Price by Type (2016-2021)
5 KETOROLAC INJECTION HISTORIC MARKET ANALYSIS BY APPLICATION: 5.1 Global Ketorolac Injection Sales Market Share by Application (2016-2021); 5.2 Global Ketorolac Injection Revenue Market Share by Application (2016-2021); 5.3 Global Ketorolac Injection Price by Application (2016-2021)
6 KEY COMPANIES PROFILED: 6.1 Pfizer; 6.1.1 Pfizer Corporation Information; 6.1.2 Pfizer Description and Business Overview; 6.1.3 Pfizer Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021); 6.1.4 Pfizer Ketorolac Injection Product Portfolio; 6.1.5 Pfizer Recent Developments/Updates; 6.2 Fresenius Kabi; 6.2.1 Fresenius Kabi Corporation Information; 6.2.2 Fresenius Kabi Description and Business Overview; 6.2.3 Fresenius Kabi Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021); 6.2.4 Fresenius Kabi Ketorolac Injection Product Portfolio; 6.2.5 Fresenius Kabi Recent Developments/Updates; 6.3 Fosun Pharma (Gland Pharma); 6.3.1 Fosun Pharma (Gland Pharma) Corporation Information; 6.3.2 Fosun Pharma (Gland Pharma) Description and Business Overview; 6.3.3 Fosun Pharma (Gland Pharma) Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021); 6.3.4 Fosun Pharma (Gland Pharma) Ketorolac Injection Product Portfolio; 6.3.5 Fosun Pharma (Gland Pharma) Recent Developments/Updates; 6.4 Sagent Pharmaceuticals; 6.4.1 Sagent Pharmaceuticals Corporation Information; 6.4.2 Sagent Pharmaceuticals Description and Business Overview; 6.4.3 Sagent Pharmaceuticals Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021); 6.4.4 Sagent Pharmaceuticals Ketorolac Injection Product Portfolio; 6.4.5 Sagent Pharmaceuticals Recent Developments/Updates; 6.5 Hikma; 6.5.1 Hikma Corporation Information; 6.5.2 Hikma Description and Business Overview; 6.5.3 Hikma Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021); 6.5.4 Hikma Ketorolac Injection Product Portfolio; 6.5.5 Hikma Recent Developments/Updates; 6.6 Lunan Pharma; 6.6.1 Lunan Pharma Corporation Information; 6.6.2 Lunan Pharma Description and Business Overview; 6.6.3 Lunan Pharma Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021); 6.6.4 Lunan Pharma Ketorolac Injection Product Portfolio; 6.7 Alvogen; 6.7.1 Alvogen Corporation Information; 6.7.2 Alvogen Description and Business Overview; 6.7.3 Alvogen Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021); 6.7.4 Alvogen Ketorolac Injection Product Portfolio; 6.7.5 Alvogen Recent Developments/Updates; 6.8 Chengdu Brilliant Pharmaceuticals; 6.8.1 Chengdu Brilliant Pharmaceuticals Corporation Information; 6.8.2 Chengdu Brilliant Pharmaceuticals Description and Business Overview; 6.8.3 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021); 6.8.4 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Product Portfolio; 6.8.5 Chengdu Brilliant Pharmaceuticals Recent Developments/Updates; 6.9 Athenex; 6.9.1 Athenex Corporation Information; 6.9.2 Athenex Description and Business Overview; 6.9.3 Athenex Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021); 6.9.4 Athenex Ketorolac Injection Product Portfolio; 6.9.5 Athenex Recent Developments/Updates; 6.10 Sichuan Medcalo; 6.10.1 Sichuan Medcalo Corporation Information; 6.10.2 Sichuan Medcalo Description and Business Overview; 6.10.3 Sichuan Medcalo Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021); 6.10.4 Sichuan Medcalo Ketorolac Injection Product Portfolio; 6.10.5 Sichuan Medcalo Recent Developments/Updates; 6.11 Julphar Bangladesh Ltd.; 6.11.1 Julphar Bangladesh Ltd. Corporation Information; 6.11.2 Julphar Bangladesh Ltd. Description and Business Overview; 6.11.3 Julphar Bangladesh Ltd. Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021); 6.11.4 Julphar Bangladesh Ltd. Ketorolac Injection Product Portfolio; 6.12 Yung Shin Pharm; 6.12.1 Yung Shin Pharm Corporation Information; 6.12.2 Yung Shin Pharm Description and Business Overview; 6.12.3 Yung Shin Pharm Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021); 6.12.4 Yung Shin Pharm Ketorolac Injection Product Portfolio; 6.12.5 Yung Shin Pharm Recent Developments/Updates; 6.13 Tianjin Chase Sun Pharmaceutical; 6.13.1 Tianjin Chase Sun Pharmaceutical Corporation Information; 6.13.2 Tianjin Chase Sun Pharmaceutical Description and Business Overview; 6.13.3 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021); 6.13.4 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Product Portfolio; 6.13.5 Tianjin Chase Sun Pharmaceutical Recent Developments/Updates; 6.14 ZISKA Pharmaceuticals; 6.14.1 ZISKA Pharmaceuticals Corporation Information; 6.14.2 ZISKA Pharmaceuticals Description and Business Overview; 6.14.3 ZISKA Pharmaceuticals Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021); 6.14.4 ZISKA Pharmaceuticals Ketorolac Injection Product Portfolio; 6.14.5 ZISKA Pharmaceuticals Recent Developments/Updates
7 KETOROLAC INJECTION MANUFACTURING COST ANALYSIS: 7.1 Ketorolac Injection Key Raw Materials Analysis; 7.1.1 Key Raw Materials; 7.1.2 Key Suppliers of Raw Materials; 7.2 Proportion of Manufacturing Cost Structure; 7.3 Ketorolac Injection Industrial Chain Analysis
8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS: 8.1 Marketing Channel; 8.2 Ketorolac Injection Distributors List; 8.3 Ketorolac Injection Customers
9 KETOROLAC INJECTION MARKET DYNAMICS: 9.1 Ketorolac Injection Industry Trends; 9.2 Ketorolac Injection Growth Drivers; 9.3 Ketorolac Injection Market Challenges; 9.4 Ketorolac Injection Market Restraints
10 GLOBAL MARKET FORECAST: 10.1 Ketorolac Injection Market Estimates and Projections by Type; 10.1.1 Global Forecasted Sales of Ketorolac Injection by Type (2022-2027); 10.1.2 Global Forecasted Revenue of Ketorolac Injection by Type (2022-2027); 10.2 Ketorolac Injection Market Estimates and Projections by Application; 10.2.1 Global Forecasted Sales of Ketorolac Injection by Application (2022-2027); 10.2.2 Global Forecasted Revenue of Ketorolac Injection by Application (2022-2027); 10.3 Ketorolac Injection Market Estimates and Projections by Region; 10.3.1 Global Forecasted Sales of Ketorolac Injection by Region (2022-2027); 10.3.2 Global Forecasted Revenue of Ketorolac Injection by Region (2022-2027)
11 RESEARCH FINDINGS AND CONCLUSION
12 METHODOLOGY AND DATA SOURCE: 12.1 Methodology/Research Approach; 12.1.1 Research Programs/Design; 12.1.2 Market Size Estimation; 12.1.3 Market Breakdown and Data Triangulation; 12.2 Data Source; 12.2.1 Secondary Sources; 12.2.2 Primary Sources; 12.3 Author List; 12.4 Disclaimer
List of Tables: Table 1. Global Ketorolac Injection Sales (K Units) Growth Rate Comparison by Type (2021-2027); Table 2. Global Ketorolac Injection Sales (K Units) Comparison by Application (2021-2027); Table 3. Global Ketorolac Injection Market Size by Region (US$ Million): 2016 VS 2021 VS 2027; Table 4. Key Manufacturers Ketorolac Injection Covered in This Study; Table 5. Global Ketorolac Injection Sales (K Units) of Key Manufacturers (2016-2021); Table 6. Global Ketorolac Injection Sales Market Share by Manufacturers (2016-2021); Table 7. Global Ketorolac Injection Revenue (US$ Million) by Manufacturers (2016-2021); Table 8. Global Ketorolac Injection Revenue Share by Manufacturers (2016-2021); Table 9. Global Market Ketorolac Injection Average Price (US$/K Units) of Key Manufacturers (2016-2021); Table 10. Manufacturers Ketorolac Injection Manufacturing Sites and Area Served; Table 11. Manufacturers Ketorolac Injection Product Type; Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI); Table 13. Global Ketorolac Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ketorolac Injection as of 2020); Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans; Table 15. Global Ketorolac Injection Sales by Region (2016-2021) & (K Units); Table 16. Global Ketorolac Injection Sales Market Share by Region (2016-2021); Table 17. Global Ketorolac Injection Revenue by Region (2016-2021) & (US$ Million); Table 18. North America Ketorolac Injection Sales by Country (2016-2021) & (K Units); Table 19. North America Ketorolac Injection Sales Market Share by Country (2016-2021); Table 20. North America Ketorolac Injection Revenue by Country (2016-2021) & (US$ Million); Table 21. North America Ketorolac Injection Revenue Market Share by Country (2016-2021); Table 22. Europe Ketorolac Injection Sales by Country (2016-2021) & (K Units); Table 23. Europe Ketorolac Injection Sales Market Share by Country (2016-2021); Table 24. Europe Ketorolac Injection Revenue by Country (2016-2021) & (US$ Million); Table 25. Europe Ketorolac Injection Revenue Market Share by Country (2016-2021); Table 26. Asia Pacific Ketorolac Injection Sales by Region (2016-2021) & (K Units); Table 27. Asia Pacific Ketorolac Injection Sales Market Share by Region (2016-2021); Table 28. Asia Pacific Ketorolac Injection Revenue by Region (2016-2021) & (US$ Million); Table 29. Asia Pacific Ketorolac Injection Revenue Market Share by Region (2016-2021); Table 30. Latin America Ketorolac Injection Sales by Country (2016-2021) & (K Units); Table 31. Latin America Ketorolac Injection Sales Market Share by Country (2016-2021); Table 32. Latin America Ketorolac Injection Revenue by Country (2016-2021) & (US$ Million); Table 33. Latin America Ketorolac Injection Revenue Market Share by Country (2016-2021); Table 34. Middle East and Africa Ketorolac Injection Sales by Country (2016-2021) & (K Units); Table 35. Middle East and Africa Ketorolac Injection Sales Market Share by Country (2016-2021); Table 36. Middle East and Africa Ketorolac Injection Revenue by Country (2016-2021) & (US$ Million); Table 37. Middle East and Africa Ketorolac Injection Revenue Market Share by Country (2016-2021); Table 38. Global Ketorolac Injection Sales (K Units) by Type (2016-2021); Table 39. Global Ketorolac Injection Sales Market Share by Type (2016-2021); Table 40. Global Ketorolac Injection Revenue (US$ Million) by Type (2016-2021); Table 41. Global Ketorolac Injection Revenue Share by Type (2016-2021); Table 42. Global Ketorolac Injection Price (US$/K Units) by Type (2016-2021); Table 43. Global Ketorolac Injection Sales (K Units) by Application (2016-2021); Table 44. Global Ketorolac Injection Sales Market Share by Application (2016-2021); Table 45. Global Ketorolac Injection Revenue (US$ Million) by Application (2016-2021); Table 46. Global Ketorolac Injection Revenue Share by Application (2016-2021); Table 47. Global Ketorolac Injection Price (US$/K Units) by Application (2016-2021); Table 48. Pfizer Corporation Information; Table 49. Pfizer Description and Business Overview; Table 50. Pfizer Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021); Table 51. Pfizer Recent Developments/Updates; Table 52. Fresenius Kabi Corporation Information; Table 53. Fresenius Kabi Description and Business Overview; Table 54. Fresenius Kabi Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021); Table 55. Fresenius Kabi Recent Developments/Updates 49